Knowledge is the first step.

Testosterone replacement therapy (TRT) is a clinician-prescribed treatment that restores testosterone to optimal physiological levels. It is prescribed after comprehensive bloodwork confirms a clinical deficiency, and is managed by a licensed prescriber like Crystal Troup, NP. It is not a performance-enhancing drug — it is a medically supervised hormone replacement protocol.

Common symptoms include chronic fatigue, low libido, difficulty building or maintaining muscle, increased body fat (especially abdominal), brain fog, irritability, poor sleep, and loss of motivation. These symptoms are often dismissed as "normal aging" — but they are not normal, and they are treatable.

Lab reference ranges define "low" as below approximately 8–12 nmol/L, but these ranges are population averages — not optimal health targets. Crystal evaluates your total testosterone, free testosterone, SHBG, and your symptoms together. Many men with levels technically "in range" are significantly under-optimized.

Most patients notice energy and mood improvements within 2–4 weeks. Libido and sexual function often improve within 3–6 weeks. Body composition changes — more muscle, less fat — typically become visible after 3 months. Full benefits at optimized levels usually take 6–12 months.

Yes, when properly monitored. Long-term data supports TRT's safety profile when hematocrit, PSA, lipids, and cardiovascular markers are monitored regularly — which is exactly what Crystal tracks at every 90-day cycle. Unmonitored TRT carries risks; clinician-managed TRT does not.

No. Decades of research have found no causal link between TRT and prostate cancer. The "testosterone fuels prostate cancer" fear came from a single flawed study from the 1940s. Modern evidence — including the TRAVERSE trial — shows TRT does not increase prostate cancer risk in properly selected patients. Crystal screens PSA at every cycle.

TRT suppresses natural LH and FSH production, which reduces testicular testosterone production and sperm output. If fertility is a concern, Crystal can prescribe protocols that preserve or restore fertility — including hCG co-treatment or clomiphene-based alternatives. This is a conversation to have at your initial appointment.

Both are injectable testosterone esters with nearly identical half-lives and clinical outcomes. Cypionate has a half-life of approximately 8 days; enanthate is approximately 4.5–5 days. Both are typically dosed weekly or twice-weekly. Crystal chooses based on individual response, injection frequency preference, and pharmacy availability.

Not necessarily. Pellets offer convenience (implanted every 3–6 months) but sacrifice dose adjustability. If your protocol needs to change — which is common in the first year — pellets make that difficult. Injections allow Crystal to adjust your dose based on bloodwork at every cycle, which is a significant clinical advantage early in treatment.

Many workplace group benefit plans cover testosterone injections when prescribed by a licensed clinician for a documented deficiency. Coverage varies by plan, and Brett helps every patient understand and navigate their specific benefits. Some plans cover up to 100% of medication cost.

Likely yes, if you have primary hypogonadism (the testicles aren't producing adequate testosterone). If your low T is driven by lifestyle factors, stress, or secondary causes, Crystal may be able to restore natural production with targeted intervention. This is assessed case by case.

"Normal" on a standard lab range means you're not in the bottom 2.5% of the population — it doesn't mean you're optimized. Crystal evaluates your free testosterone, SHBG, symptoms, and the full clinical picture. Many patients on TRT had levels technically in range but were functionally under-optimized. Schedule a consultation to find out where you stand.

Crystal orders a comprehensive panel including: total testosterone, free testosterone, SHBG, LH, FSH, estradiol (E2), hematocrit/CBC, PSA (men over 40), thyroid (TSH, free T3, T4), cortisol, lipid panel, fasting glucose and insulin, liver and kidney function. This is far more thorough than a standard GP panel.

No. Most TRT protocols use weekly or twice-weekly injections. Daily injections exist (typically SubQ with insulin syringes) and can produce more stable levels with fewer peaks and troughs — but they're not required. Crystal designs your injection frequency based on the ester you're using, your labs, and your lifestyle.

TRT can slightly raise hematocrit (red blood cell count) and modestly affect HDL/LDL ratios in some patients. Crystal monitors both at every cycle and adjusts dosing if needed. For most patients, optimized testosterone levels actually improve cardiovascular risk markers — particularly when combined with body composition improvements.

Yes, particularly when depression is driven by hormonal deficiency. Testosterone plays a direct role in dopamine and serotonin pathways. Many patients on TRT report significant mood improvement, reduced anxiety, and better emotional resilience — often within weeks. This doesn't replace therapy for clinical depression, but it addresses an underlying hormonal driver that antidepressants don't touch.

Borderline levels — often called "low-normal" — are one of the most common situations Crystal encounters. The clinical decision is based on your full panel, your symptom burden, and your goals. Crystal doesn't treat a number; she treats a person. Many borderline patients benefit significantly from optimization.

Crystal prescribes directly to a licensed Ontario pharmacy. The medication — whether testosterone cypionate, enanthate, or another form — is dispensed and mailed discreetly to your door. No in-person pharmacy trips. No awkward conversations. Crystal handles all the prescription coordination through our EHR.

HRT for women involves replacing estrogen, progesterone, and often testosterone that decline during perimenopause and menopause. Crystal tailors each protocol based on your bloodwork, symptoms, and personal health history. Modern HRT — particularly bioidentical formulations — has an excellent safety profile when properly dosed and monitored.

There is no minimum age. Perimenopause can begin in the early 40s — and for some women, even the late 30s. If you have symptoms (irregular cycles, mood changes, sleep disruption, low libido, brain fog), Crystal can run a full hormonal panel to assess where you are. Age is not the trigger — symptoms and bloodwork are.

Perimenopause symptoms include irregular or heavier periods, hot flashes, night sweats, sleep disturbances, mood swings, anxiety, brain fog, vaginal dryness, low libido, weight gain (especially abdominal), and joint pain. Many women are told these are "normal" — they are real, they are hormonal, and they are treatable.

The cancer scare around HRT came largely from the 2002 WHI study, which used outdated synthetic hormones and was misinterpreted. Modern bioidentical HRT has a substantially better safety profile. Current evidence shows that for most women, the benefits of HRT — including cardiovascular protection, bone density, and quality of life — significantly outweigh the risks. Crystal reviews your personal risk profile before prescribing.

Bioidentical hormones are molecularly identical to the hormones your body produces. Synthetic hormones (like those in older HRT formulations) are chemically modified analogs. Crystal primarily prescribes bioidentical estradiol and micronized progesterone — the same molecular structure your body already recognizes — which generally produces better tolerability.

No — in fact, properly dosed HRT often helps with the hormonal weight gain associated with menopause. Declining estrogen increases central adiposity (belly fat). Restoring estrogen, improving insulin sensitivity, and optimizing metabolism can actually reverse this pattern. Some patients notice water retention early on, which typically resolves.

Hot flashes are just one possible symptom of estrogen decline — many women never get them but still experience cognitive, mood, libido, sleep, and bone density effects. If your bloodwork shows declining estrogen and you have symptoms like brain fog, fatigue, or low libido — HRT is worth discussing regardless of whether you're having hot flashes.

Most women notice sleep and hot flash improvement within 2–4 weeks. Mood, energy, and cognitive improvements typically follow within 4–8 weeks. Vaginal tissue and libido improvements often take 8–12 weeks. Full effects — including bone density and cardiovascular — take 6–12 months of consistent use.

If you've had a hysterectomy (uterus removed), the primary reason for adding progesterone — uterine lining protection — is eliminated. However, progesterone has independent neurological and mood-stabilizing benefits that many women find valuable. Crystal discusses your full symptom picture to decide if progesterone adds benefit for you personally.

Family history is a conversation to have with Crystal — it doesn't automatically disqualify you. The risk depends on specific genetic factors, the type of cancer in your family, and your personal risk profile. Crystal reviews your full history and, where needed, may recommend genetic counseling before prescribing. This is an individual clinical decision, not a blanket rule.

Women naturally produce testosterone — and it declines significantly during perimenopause. Low testosterone in women causes reduced libido, fatigue, cognitive decline, and mood issues. Low-dose testosterone supplementation for women has a strong evidence base for improving these symptoms and is a standard part of Crystal's comprehensive HRT approach.

Crystal orders: estradiol, progesterone, total and free testosterone, SHBG, FSH, LH, TSH and free thyroid hormones, cortisol, fasting insulin and glucose, CBC, lipid panel, and liver function. The full picture — not just the obvious numbers — allows Crystal to design a protocol that addresses the root cause of your symptoms.

Yes — and this is one of the most underappreciated benefits of HRT. Estrogen plays a direct role in brain function, memory consolidation, and neurotransmitter activity. Many women report significant cognitive improvements within weeks of starting HRT. The "brain fog" of perimenopause is hormonal — and it responds to hormonal treatment.

Properly dosed HRT typically improves mood — it doesn't worsen it. Some women experience transient mood fluctuations during the first few weeks as their body adapts. If mood worsens or doesn't improve, Crystal adjusts the protocol — usually the balance between estrogen and progesterone. This is why monitoring matters.

Yes. Perimenopause — the transition phase before full menopause — can last 4–10 years, and hormonal fluctuations during this time cause significant symptoms. You don't need to have stopped menstruating to qualify for HRT. Crystal tailors the protocol appropriately for premenopausal, perimenopausal, and postmenopausal patients.

Growth hormone (GH) is produced by the pituitary gland and drives tissue repair, fat metabolism, muscle synthesis, immune function, sleep quality, and cognitive health. It peaks in your 20s and declines roughly 15% per decade after that. By your 40s, you may have half the GH output you had at 25 — which shows up as reduced recovery, increased body fat, poor sleep, and lower energy.

Secretagogues are peptides that stimulate the pituitary gland to produce and release more of your own growth hormone — rather than replacing it externally. This approach preserves the body's natural pulsatile release pattern and avoids the side effects and regulatory issues associated with exogenous HGH. Crystal uses secretagogue protocols as a safer, more sustainable alternative.

Benefits of optimized GH include: improved sleep depth and quality, reduced visceral fat (particularly the stubborn abdominal kind), enhanced muscle synthesis and recovery, better skin elasticity, improved cognitive function, and increased energy. These effects compound over time — most patients report dramatic differences at 3–6 months.

Human growth hormone (somatropin) is a prescription drug in Canada, legal when prescribed by a licensed clinician for appropriate clinical indications. Growth hormone secretagogues (peptides like sermorelin and ipamorelin) occupy a different regulatory category. Crystal prescribes within Canadian health regulations — all medications dispensed through licensed pharmacies.

GLP-1 receptor agonists — including semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro) — work at the hormonal and neurological level to reduce appetite, quiet food cravings, slow gastric emptying, and improve insulin sensitivity. Crystal prescribes and monitors these medications as part of a structured clinical protocol.

When you restrict calories, your body compensates by lowering your metabolic rate and increasing hunger hormones like ghrelin. This is not a character flaw — it is an evolved biological mechanism. GLP-1 medications work at the hormonal level to interrupt this cycle, making sustainable weight loss achievable for the first time.

Some muscle loss during significant weight loss is possible but largely preventable. Crystal addresses this by combining GLP-1 protocols with adequate protein intake guidance and, when appropriate, co-prescribing TRT or HRT to preserve lean tissue. The goal is fat loss, not weight loss — and Crystal manages your protocol with that distinction in mind.

Yes. Crystal Troup, NP is a licensed Ontario Nurse Practitioner with full prescribing authority. She can prescribe Ozempic, Wegovy, and Mounjaro via telemedicine after a comprehensive metabolic bloodwork review and clinical assessment. No in-person appointment required.

Yes — significantly. GLP-1 medications improve insulin sensitivity, lower blood sugar and HbA1c, reduce blood pressure, lower cardiovascular risk, and improve lipid profiles. Recent evidence also suggests cardiovascular and kidney-protective effects independent of weight loss. Crystal monitors all of these markers quarterly.

ED is most commonly caused by vascular, hormonal, or neurological factors — not psychological ones, despite the myth. Low testosterone suppresses libido and erection quality. Cardiovascular disease reduces blood flow to penile tissue. Diabetes and insulin resistance damage nerve conduction. Crystal evaluates all of these pathways and often finds an addressable root cause that goes undetected in standard GP visits.

Sildenafil (Viagra) has a 4–6 hour window and requires timing relative to sexual activity. Tadalafil (Cialis) has a 36-hour window and can be taken daily at a lower dose for continuous effect. Both are PDE5 inhibitors that improve blood flow. Crystal prescribes based on lifestyle preference — daily low-dose tadalafil is often preferred for its spontaneity.

Male pattern hair loss is caused by DHT (dihydrotestosterone) — a potent androgen converted from testosterone by the enzyme 5-alpha reductase. DHT binds to follicle receptors in genetically susceptible areas of the scalp and progressively miniaturizes the follicle until it stops producing hair. Genetics determines susceptibility; DHT drives the actual loss.

It can, in genetically susceptible individuals. More testosterone means more substrate for DHT conversion. However, Crystal can co-prescribe finasteride or dutasteride to block 5-alpha reductase — preventing DHT conversion while optimizing testosterone. Many TRT patients successfully preserve or even improve their hair by combining TRT with DHT-blocking protocols.

In Ontario, Nurse Practitioners have autonomous prescribing authority — meaning Crystal prescribes independently, not under physician oversight. NPs typically have more time per patient, are more accessible for follow-up, and many specialize deeply in areas like hormone optimization. Crystal's 15+ years of focused clinical experience often exceeds what a GP generalist brings to hormone care.

Yes. Crystal is licensed in Ontario, Canada and can only see patients who are physically located in Ontario at the time of their appointment. This applies to telehealth as well — provincial licensing governs where you are at the time of the consultation, not where you live permanently.

Crystal issues your bloodwork requisition digitally. Ava helps you find the nearest LifeLabs or Dynacare location. You complete your bloodwork at the lab, results upload directly to your chart, and Crystal reviews and interprets them before your follow-up appointment. The entire process is coordinated — you don't have to chase anything down.

It means Crystal Troup, NP is the only clinician who ever sees you. Not a different NP each time. Not a PA. Not a rotating roster. Crystal — every time. She knows your history, your protocol history, your goals, and your response to treatment. This is the standard most clinics claim to offer. At Tier1, it's structural.

Most large telehealth clinics optimize for volume — rotating providers, scripted protocols, and automated follow-up. Tier1 Optimal is built around one clinician seeing the same patients, with hands-on coordination from Brett and 24/7 concierge support from Ava. You are not a ticket number here. You're a patient with a name, a history, and an actual relationship with your clinician.

Book a free consultation with Brett below — no credit card required. He'll walk you through the plans, pricing, insurance options, and what your first 90 days look like. If you're ready to start clinical care right away, you can also book directly with Crystal through our EHR. Either way, we make it simple.